Explore the details of the Bayer Pharma Ag V. Macleods Pharmaceuticals Ltd. case under case number 1:25cv00719 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25cv00719
Filing Date
Jun 9, 2025
Cause of Action
Patent Infringement
Status
-
Case Link
View Case
Nature of Suit
Patent

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Janssen Pharmaceuticals, Inc. -
Bayer Pharma AG -
Macleods Pharmaceuticals Ltd. -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US10828310B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 9, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US, 10,828,310. (mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025[SEALED] COMPLAINT with Jury Demand against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. (Filing fee $ 405, receipt number ADEDC-4706261) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)PACER Document
Jun 9, 2025Remark: The MDL Panel has been notified of case 1:25-cv-00719-UNA which relates with 1:21-md-03017-RGA-LDH (mrr)PACER Document
Jun 9, 2025Remark: Exit electronic copies to Judge, RGA (mrr)PACER Document
Jun 9, 2025ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 6/9/2025. (aas) (Entered: 06/09/2025)PACER Document
Jun 9, 2025CORRECTING ENTRY: The docket text for D.I. 5 has been amended. The patent number has been corrected. The NEF for D.I. 5 has been regenerated. (nms)PACER Document
Jun 11, 2025Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00719-UNA, 1:25-cv-00694-UNA (alb)PACER Document
Jun 9, 2025MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025)Attachment